Artificial intelligence is poised to improve pregnancy care, including for those with conditions such as fetal and neonatal alloimmune thrombocytopenia (FNAIT), by enabling earlier detection, more personalized monitoring and better access to care while still relying on clinicians for final decisions, according to a report published recently in Gynecology and Obstetrics.
For patients, this means care may become more proactive, convenient, and tailored to individual risks rather than based on a one-size-fits-all schedule.
One major shift is where care happens. Traditional prenatal care relies on frequent in-person visits, which can be difficult for many patients to attend. AI-supported tools, combined with connected home devices, could bring parts of the clinic into the home.
Patients might use devices to check blood levels, glucose, or other markers, with results automatically interpreted by AI. For someone at risk of FNAIT, where close monitoring of fetal health is critical, this could allow earlier detection of complications without constant travel to a clinic.
This approach builds on changes seen during the COVID-19 pandemic, when telemedicine expanded rapidly. New models, such as the proposed “PregCare” framework, suggest that AI could safely reduce the number of in-person visits by up to half while maintaining oversight through virtual care teams. For patients, this may mean fewer disruptions to daily life and improved access, especially in underserved or remote areas.
Read more about treatment and care of FNAIT
AI is also changing how care is delivered by making it more personalized. Current risk assessments often rely on static models that do not fully reflect how pregnancy conditions evolve. AI systems can continuously analyze data and update predictions over time. In conditions like FNAIT, where risk can change quickly, this could help clinicians anticipate complications earlier and adjust monitoring or treatment plans accordingly.
Wearable devices such as smartwatches and rings add another layer of insight by tracking real-time health data like heart rate, blood pressure, and activity levels. These tools may help guide treatment decisions and improve medication adherence. Continuous monitoring provides a more accurate picture than single clinic measurements, which can miss important fluctuations.
AI may also support the healthcare workforce. Tools that assist with ultrasound imaging, summarize clinical notes, or generate patient education materials can reduce workload and improve consistency.
“Close collaboration between clinicians and industry is essential to develop digital solutions that enhance clinical practice without compromising human aspects of care, essentially utilizing AI to augment rather than replace human caregivers,” emphasized the authors of this report.
Looking ahead, the benefits of AI will depend on careful implementation. Systems must be transparent, tested across diverse populations, and designed to protect patient data. For patients with conditions like FNAIT, the promise is meaningful: earlier diagnosis, more individualized care, and better outcomes, delivered through a combination of advanced technology and trusted clinical expertise.
Sign up here to get the latest news, perspectives, and information about FNAIT sent directly to your inbox. Registration is free and only takes a minute.
